Alliqua Inc fka ALQA

[Giannuzzo]

Good read.

Opinion: We’re in the year of the biotech buyout
http://www.marketwatch.com/story/were-in-the-year-of-the-biotech-buyout-and-here-are-five-prime-targets-2017-01-23?siteid=yhoof2

"This means that many drug companies are becoming more and more dependent on a narrower base of products. Celgene $CELG, is a good example. It reported $11.2 billion in revenue last year, and almost $7 billion of that came from Revlimid, a cancer drug."

Below is another insight to what's happening in the current wound industry:
http://www.brocair.com/pdfs/Wound_Care_Market_Report_Mar_2015.pdf

"Overall, the wound care industry is showing renewed signs of growth as the demand for the products remain strong due to the aging population. There will also be a shift in focus in the coming years towards advanced wound care products including biological dressings and negative pressure wound therapy devices."